ERBB2 and breast cancer: Previous study has shown that autophagy plays a crucial role in lapatinib (a HER2 inhibitor)-induced breast cancer cell death.24–26 Therefore, we analyzed if autophagy is highly correlated with the combination treatment-induced cell death.